Rhabdomyosarcoma Global Clinical Trials Review, H1, 2012
GlobalData
January 27, 2012 118 Pages - SKU: GBDT6797475
|
|
Rhabdomyosarcoma Global Clinical Trials Review, H1, 2012
Summary
GlobalData's clinical trial report, “Rhabdomyosarcoma Global Clinical Trials Review, H1, 2012 provides data on the Rhabdomyosarcoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Rhabdomyosarcoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Rhabdomyosarcoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
|
- Introduction
- Rhabdomyosarcoma
- Report Guidance
- Clinical Trials by Region
- Clinical Trials by Country
- Top Countries Contributing to Clinical Trials in Asia-Pacific
- Top Five Countries Contributing to Clinical Trials in Europe
- Top Countries Contributing to Clinical Trials in North America
- Top Countries Contributing to Clinical Trials in Central and South America
- Clinical Trials by BRIC Nations
- Clinical Trials by G7 Nations
- Clinical Trials in G7 Nations by Trial Status
- Clinical Trials by E7 Nations
- Clinical Trials in E7 Nations by Trial Status
- Clinical Trials by Phase
- In Progress Trials by Phase
- Clinical Trials by Trial Status
- Unaccomplished Trials of Rhabdomyosarcoma
- Subjects Recruited Over a Period of Time
- Prominent Sponsors
- Top Companies Participating in Rhabdomyosarcoma Therapeutics Clinical Trials
- Prominent Drug Comparison
- Clinical Trial Profiles
- Clinical Trial Overview of Top Companies
- Jennerex Biotherapeutics, Inc.
- Clinical Trial Overview of Jennerex Biotherapeutics, Inc.
- Novartis AG
- Clinical Trial Overview of Novartis AG
- Daiichi Sankyo Company, Limited
- Clinical Trial Overview of Daiichi Sankyo Company, Limited
- Eli Lilly and Company
- Clinical Trial Overview of Eli Lilly and Company
- F. Hoffmann-La Roche Ltd.
- Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
- Clinical Trial Overview of Top Universities / Institutes / Hospitals
- St. Jude Children’s Research Hospital, Inc.
- Clinical Trial Overview of St. Jude Children’s Research Hospital, Inc.
- Fred Hutchinson Cancer Research Center
- Clinical Trial Overview of Fred Hutchinson Cancer Research Center
- Children's Memorial Hospital
- Clinical Trial Overview of Children's Memorial Hospital
- Medical College of Wisconsin
- Clinical Trial Overview of Medical College of Wisconsin
- Hospital Santa Marcelina
- Clinical Trial Overview of Hospital Santa Marcelina
- European Paediatric Soft Tissue Sarcoma Study Group
- Clinical Trial Overview of European Paediatric Soft Tissue Sarcoma Study Group
- City of Hope National Medical Center
- Clinical Trial Overview of City of Hope National Medical Center
- Fundacio Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- Clinical Trial Overview of Fundacio Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- Sarcoma Alliance for Research through Collaboration
- Clinical Trial Overview of Sarcoma Alliance for Research through Collaboration
- Centre Oscar Lambret
- Clinical Trial Overview of Centre Oscar Lambret
- Memorial Sloan Kettering Cancer Center
- Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
- Dana-Farber Cancer Institute
- Clinical Trial Overview of Dana-Farber Cancer Institute
- Emory University
- Clinical Trial Overview of Emory University
- University Hospital Basel
- Clinical Trial Overview of University Hospital Basel
- Stanford University
- Clinical Trial Overview of Stanford University
- Penn State University
- Clinical Trial Overview of Penn State University
- Massachusetts General Hospital
- Clinical Trial Overview of Massachusetts General Hospital
- Five Key Clinical Profiles
- Appendix
- Abbreviations
- Definitions
- Research Methodology
- Secondary Research
- About GlobalData
- Contact Us
- Disclaimer
- Source
- List of Tables
- Rhabdomyosarcoma Therapeutics Market, Global, Clinical Trials by Zone, 2012*
- Rhabdomyosarcoma Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
- Rhabdomyosarcoma Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
- Rhabdomyosarcoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2012*
- Rhabdomyosarcoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2012*
- Rhabdomyosarcoma Therapeutics Clinical Trials, North America, Top Countries, 2012*
- Rhabdomyosarcoma Therapeutics Clinical Trials, Central and South America, Top Countries, 2012*
- Rhabdomyosarcoma Therapeutics Clinical Trials, BRIC Countries, 2012*
- Rhabdomyosarcoma Therapeutics Clinical Trials, G7 Countries, 2012*
- Rhabdomyosarcoma Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
- Rhabdomyosarcoma Therapeutics Clinical Trials, E7 Countries, 2012*
- Rhabdomyosarcoma Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
- Rhabdomyosarcoma Therapeutics Market, Global, Clinical Trials by Phase, 2012*
- Rhabdomyosarcoma Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012*
- Rhabdomyosarcoma Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
- Rhabdomyosarcoma Therapeutics Market, Global, Withdrawn Clinical Trials, 2012*
- Rhabdomyosarcoma Therapeutics Market, Global, Terminated Clinical Trials, 2012*
- Rhabdomyosarcoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
- Rhabdomyosarcoma Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
- Rhabdomyosarcoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
- Rhabdomyosarcoma Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
- Rhabdomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Jennerex Biotherapeutics, Inc., 2012*
- Rhabdomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012*
- Rhabdomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2012*
- Rhabdomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2012*
- Rhabdomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2012*
- Rhabdomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Jude Children’s Research Hospital, Inc., 2012*
- Rhabdomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2012*
- Rhabdomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Memorial Hospital, 2012*
- Rhabdomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical College of Wisconsin, 2012*
- Rhabdomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Santa Marcelina, 2012*
- Rhabdomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by European Paediatric Soft Tissue Sarcoma Study Group, 2012*
- Rhabdomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by City of Hope National Medical Center, 2012*
- Rhabdomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Fundacio Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, 2012*
- Rhabdomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sarcoma Alliance for Research through Collaboration, 2012*
- Rhabdomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Oscar Lambret, 2012*
- Rhabdomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2012*
- Rhabdomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, 2012*
- Rhabdomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2012*
- Rhabdomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Basel, 2012*
- Rhabdomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2012*
- Rhabdomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Penn State University, 2012*
- Rhabdomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2012*
- List of Figures
- Rhabdomyosarcoma Therapeutics Market, Global, Clinical Trials by Zone (%), 2012*
- Rhabdomyosarcoma Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
- Rhabdomyosarcoma Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
- Rhabdomyosarcoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2012*
- Rhabdomyosarcoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012*
- Rhabdomyosarcoma Therapeutics Clinical Trials, North America, Top Countries (%), 2012*
- Rhabdomyosarcoma Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2012*
- Rhabdomyosarcoma Therapeutics Clinical Trials, G7 Countries (%), 2012*
- Rhabdomyosarcoma Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
- Rhabdomyosarcoma Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
- Rhabdomyosarcoma Therapeutics Market, Global, Clinical Trials by Phase (%), 2012*
- Rhabdomyosarcoma Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012*
- Rhabdomyosarcoma Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
- Rhabdomyosarcoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
- Rhabdomyosarcoma Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
- Rhabdomyosarcoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
- Rhabdomyosarcoma Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
- GlobalData Methodology
Share this report
Other tasks Related Markets Clinical Trial Reports Free Alert Me service Receive bi-weekly email alerts on new market research Sign Up Today!
|
